Related Experiment Videos
In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds
Dieter Rehder1, João Costa Pessoa, Carlos F G C Geraldes
1Institute of Inorganic and Applied Chemistry, University of Hamburg, 20146 Hamburg, Germany. rehder@xray.chemie.uni-hamburg.de
Abstract:
A representative set of vanadium(IV and V) compounds in varying coordination environments has been tested in the concentration range 1 to 10(-6) mM, using transformed mice fibroblasts (cell line SV 3T3), with respect to their short-term cell toxicity (up to 36 hours) and their ability to stimulate glucose uptake by cells. These insulin-mimetic tests have also been carried out with non-transformed human fibroblasts (cell line F26). The compounds under investigation comprise established insulin-mimetic species such as vanadate ([H(2)VO(4)](-)), [VO(acetylacetonate)(2)], [VO(2)(dipicolinate)](-) and [VO(maltolate)(2)], and new systems and coordination compounds containing OO, ON, OS, NS and ONS donor atom sets. A vitality test assay, measuring the reduction equivalents released in the mitochondrial respiratory chain by intracellular glucose degradation, is introduced and the results are counter-checked with (3)H-labelled glucose. Most compounds are toxic at the 1 mM concentration level, and most compounds are essentially non-toxic and about as effective as or more potent than insulin at concentrations of 0.01 mM and below. V(V) compounds tend to be less toxic than V(IV)compounds, and complexes containing thio functional ligands are somewhat more toxic than others. Generally, ON ligation is superior in insulin-mimetic efficacy to OO or O/ NS coordination, irrespective of the vanadium oxidation state. There is, however, no striking correlation between the nature of the ligand systems and the insulin-mimetic potency in these cell culture tests, encompassing 41 vanadium compounds, the results on 22 of which are reported in detail here. The syntheses and characteristics of various new compounds are provided together with selected speciation results. The crystal and molecular structures of [[VO(naph-tris)](2)] [where naph-tris is the Schiff base formed between o-hydroxynaphthaldehyde and tris(hydroxymethyl)amine] are reported. Electronic supplementary material to this paper can be obtained by using the Springer Link server located at http://dx.doi.org/10.1007/s00775-001-0311-5.
Insights
Vanadium compounds show insulin-mimetic properties, stimulating glucose uptake in cells. While toxicity varies, some vanadium compounds are effective and less toxic than insulin at low concentrations.
Area of Science:
- Inorganic Chemistry
- Biochemistry
- Toxicology
Background:
- Insulin resistance is a key factor in metabolic disorders.
- Vanadium compounds have shown potential as insulin mimetics.
- Understanding the structure-activity relationship of vanadium compounds is crucial for developing new therapies.
Purpose of the Study:
- To evaluate the insulin-mimetic activity and cytotoxicity of various vanadium(IV) and vanadium(V) compounds.
- To explore the influence of coordination environment and ligand type on vanadium compound efficacy.
- To introduce a new vitality test assay for measuring glucose uptake stimulation.
Main Methods:
- Testing of 41 vanadium compounds on mouse (SV 3T3) and human (F26) fibroblasts.
- Assessing short-term cell toxicity (up to 36 hours) and glucose uptake stimulation.
- Utilizing a novel vitality test assay and counter-checking with (3)H-labelled glucose.
Main Results:
- Most vanadium compounds exhibited toxicity at 1 mM but were non-toxic and potent insulin mimetics at 0.01 mM and below.
- Vanadium(V) compounds were generally less toxic than vanadium(IV) compounds.
- ON-ligated complexes showed superior insulin-mimetic efficacy compared to OO or O/NS coordination.
Conclusions:
- Vanadium compounds hold promise as insulin mimetics, with efficacy dependent on oxidation state and ligand coordination.
- Further research into vanadium compound structure-activity relationships can guide the development of novel antidiabetic agents.
- The developed vitality test assay provides a reliable method for evaluating insulin-mimetic activity.